Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia

NCT: NCT05111288 · RECRUITING

NCT IDNCT05111288
StatusRECRUITING
Start Date2022-05-18
Completion2027-12
SponsorMayo Clinic (OTHER)
First posted
Last updated

Brief Summary

This study is being done to observe the effects of treatment from a device called the Bioboosti which utilizes pulsed electromagnetic waves on its ability to improve blood flow to the heart tissue in individuals with coronary artery disease (CAD).

Frequently Asked Questions

What is Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia?

Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia is a clinical trial registered under NCT05111288. Current status: RECRUITING.

What is the status of NCT05111288?

The current status of NCT05111288 (Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia) is: RECRUITING.

When did Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia start?

Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia started on 2022-05-18.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.